The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,138.00
Bid: 3,138.00
Ask: 3,140.00
Change: -46.00 (-1.44%)
Spread: 2.00 (0.064%)
Open: 3,186.00
High: 3,192.00
Low: 3,126.00
Prev. Close: 3,184.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

29 Jun 2023 15:26

RNS Number : 4357E
Bunzl PLC
29 June 2023
 

Notification of transactions by person discharging managerial responsibilities

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 Alberto Grau

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director, Continental Europe

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bunzl plc

b)

 

LEI

 

 

213800Q1Q9DV4L78UM09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 10,972 shares at £23.75 per share following the exercise of options granted in February 2019 under Part A of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 9,491 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

£30.05979

9,491

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A single transaction

 

 

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 12,920 shares at £21.07 per share following the exercise of options granted in September 2019 under Part A of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 10,421 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

10,421

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 3

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 15,309 shares at £18.40 per share following the exercise of options granted in March 2020 under Part A of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 11,457 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

11,457

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 4

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 3,151 shares at nil cost following the exercise of an award granted in April 2019 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 1,095 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

1,095

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 5

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 6,667 shares at nil cost following the exercise of an award granted in October 2019 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 2,316 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

2,316

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 6

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 11,826 shares at nil cost following the exercise of an award granted in April 2020 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 4,108 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

4,108

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 7

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 4,187 shares at nil cost following the exercise of an award granted in March 2019 (and related dividend equivalent shares) under the Bunzl Deferred Annual Share Bonus Scheme and subsequent sale of 1,455 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs..

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

1,455

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 8

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 5,210 shares at nil cost following the exercise of an award granted in March 2020 (and related dividend equivalent shares) under the Bunzl Deferred Annual Share Bonus Scheme and subsequent sale of 1,811 shares at £30.05979 per share to cover the costs of exercise, including tax and dealing costs..

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£30.05979

1,811

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A single transaction

 

N/A

e)

 

Date of the transaction

 

 

2023-06-28

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZKLFLXQLLBBQ
Date   Source Headline
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition
15th Aug 20237:00 amRNSAcquisition
2nd Aug 20233:45 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSTotal Voting Rights
13th Jul 20234:20 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSOutcome of audit tender process
11th Jul 20234:50 pmRNSDirector/PDMR Shareholding
6th Jul 202310:44 amRNSDirector/PDMR Shareholding
3rd Jul 20234:45 pmRNSTotal Voting Rights
29th Jun 20233:26 pmRNSDirector/PDMR Shareholding
21st Jun 20234:54 pmRNSHolding(s) in Company
15th Jun 20237:00 amRNSTrading Statement
8th Jun 20238:00 amRNSAdditional Listing
5th Jun 202311:00 amRNSDirector/PDMR Shareholding
1st Jun 202311:16 amRNSTotal Voting Rights
30th May 20237:00 amRNSAcquisition
24th May 202312:16 pmRNSHolding(s) in Company
18th May 20238:00 amRNSAdditional Listing
3rd May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20234:51 pmRNSDirector/PDMR Shareholding
2nd May 202310:37 amRNSDirector/PDMR Shareholding
2nd May 202310:30 amRNSTotal Voting Rights
2nd May 202310:27 amRNSBlock listing Interim Review
27th Apr 20238:00 amRNSAdditional Listing
26th Apr 20234:34 pmRNSResult of AGM
26th Apr 20237:00 amRNSTrading Statement
20th Apr 20238:00 amRNSAdditional Listing
19th Apr 20235:20 pmRNSHolding(s) in Company
13th Apr 20235:06 pmRNSDirector/PDMR Shareholding
12th Apr 20234:43 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 20232:10 pmRNSDirector/PDMR Shareholding
11th Apr 202310:25 amRNSDirector/PDMR Shareholding
11th Apr 202310:17 amRNSDirector/PDMR Shareholding
5th Apr 20234:59 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:30 pmRNSTotal Voting Rights
3rd Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20239:35 amRNSDirector/PDMR Shareholding
30th Mar 20238:00 amRNSAdditional Listing
28th Mar 202310:58 amRNSDirector/PDMR Shareholding
28th Mar 20239:21 amRNSDirector/PDMR Shareholding
23rd Mar 20238:00 amRNSAdditional Listing
16th Mar 202312:07 pmRNSAnnual Financial Report
16th Mar 20238:00 amRNSAdditional Listing
3rd Mar 20234:56 pmRNSDirector/PDMR Shareholding
2nd Mar 20233:20 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:13 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:09 pmRNSDirector/PDMR Shareholding
1st Mar 20234:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.